Digest opened free editor
Rola Khaleda, FT editor, chooses her favorite stories in this weekly newsletter.
Novo Nordisk announced that CEO Lars Fergard Jurgenin will step down a few days after the leading drug maker of obesity drugs was reduced.
The Danish group said on Friday that it had started searching for the new CEO after agreeing with Georginson that a new leadership was needed.
“Looking at the modern Market challengesNovo said:
This is a developing story
https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F219d27f6-1bdc-4ba0-a1ed-393b834ec67a.jpg?source=next-article&fit=scale-down&quality=highest&width=700&dpr=1
Source link